BackTeva- Pharmaceutical Industries Overview

Teva- Pharmaceutical Industries Total Current Liabilities

Teva- Pharmaceutical Industries's total current liabilities is $15B.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$15.43B
↑ 34.24% YoYΔ $3.94B vs prior year quarter

Peer trimmed avg / median

Loading

Teva- Pharmaceutical Industries Total Current Liabilities History

Loading

Teva- Pharmaceutical Industries vs. peers: Total Current Liabilities Comparison

Loading

Teva- Pharmaceutical Industries Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Teva- Pharmaceutical Industries (TEVA) FAQ

As of the most recent data (September 2026), TEVA shows a total current liabilities of $15B. That compares with $11B in the prior-year period — up 34.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TEVA's total current liabilities is now $15B (was $11B) — a 34.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Teva- Pharmaceutical Industries is outperforming or lagging.

Tracking TEVA's total current liabilities over time shows whether Teva- Pharmaceutical Industries is scaling, shrinking, or reshaping that part of the business. The current reading is $15B That compares with $11B in the prior-year period — up 34.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $15B) with ownership activity and broader fundamentals.

Teva- Pharmaceutical Industries's total current liabilities is $15B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.